menu
    • menu

    Company profile for SciSparc

    NEW Drugs in Dev: 10
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 (formerly THX-110) for the...
    SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol (CBD): SCI-110 (formerly THX-110) for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; SCI-160 (formerly THX-160) for the treatment of pain

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SciSparcIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    20 Raul Wallenberg Street, Tower A Tel Aviv
    Telephone
    Telephone
    972-3-616-7055
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://scisparc.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scisparc, Clearmind Medicine Partner For Depression Therapy
    Scisparc, Clearmind Medicine Partner For Depression Therapy

    16 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/16/3256253/0/en/SciSparc-NeuroThera-Labs-Clearmind-Medicine-Collaboration-Leads-to-Patent-Application-for-Depression-Therapy.html

    GLOBENEWSWIRE
    16 Mar 2026
    Share Share
    NeuroThera Labs, Clearmind Announce Weight Loss Patent
    NeuroThera Labs, Clearmind Announce Weight Loss Patent

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254524/0/en/SciSparc-NeuroThera-Labs-Announces-Publication-of-International-Patent-in-Collaboration-with-Clearmind-Medicine-for-Novel-Therapy-Targeting-Weight-Loss-and-Fatty-Liver-Disease.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Neurothera Labs Acquires Majority Stake In Cliniquantum
    Neurothera Labs Acquires Majority Stake In Cliniquantum

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252980/0/en/SciSparc-Subsidiary-NeuroThera-Labs-75-Signs-Definitive-Agreement-to-Acquire-Majority-Stake-in-CliniQuantum-Innovator-in-Quantum-based-Clinical-trails.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    SciSparc Announces 1-For-9 Reverse Share Split
    SciSparc Announces 1-For-9 Reverse Share Split

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247356/0/en/SciSparc-Announces-1-for-9-Reverse-Share-Split.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Neurothera Labs Receives U.S. Patent For Cannabinoid Technology
    Neurothera Labs Receives U.S. Patent For Cannabinoid Technology

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230254/0/en/SciSparc-NeuroThera-Labs-Granted-U-S-Patent-for-Cannabinoid-Technology-to-Overcome-Antimicrobial-Resistance-such-as-MRSA.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    SciSparc Acquires IP Portfolio to Advance Drug Commercialization
    SciSparc Acquires IP Portfolio to Advance Drug Commercialization

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225614/0/en/SciSparc-Successfully-Completes-Acquisition-of-IP-Portfolio-Advances-Toward-Immediate-Commercialization.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search